IL-6 and its receptor(s) are found in the CNS in health and disease. Cellular sources are glial cells and neurons. Glial production of IL-6 has intensively been studied, but comparatively little is known about the induction of IL-6 in neurons. Emerging evidence suggests that IL-6 possesses neurotrophic properties. Recent data show that neuronal IL-6 expression is induced by excitatory amino acids or membrane depolarization. This implicates that IL-6 is produced not only under pathological conditions but may play a critical role as a physiological neuromodulator that is induced by neuronal activity and regulates brain functions. In the following article, the authors review the current data on IL-6 expression in neurons, with special reference to the induction of IL-6 by neuronal activity. They discuss its direct and indirect effects as a neuromodulator and speculate about the possible function of IL-6 as a physiological regulatory molecule and as a neuroprotective agent in brain pathology.
Acarin L
, Gonzalez B, Castellano B.2000. Neuronal, astroglial and microglial cytokine expression after an excitotoxic lesion in the immature rat brain. Eur J Neurosci12:3505–3520.
2.
Akira S
, Taga T, Kishimoto T.1993. Interleukin-6 in biology and medicine. Adv Immunol54:1–78.
3.
Ali C
, Nicole O, Docagne F, Lesne S, MacKenzie ET, Nouvelot A, and others. 2000. Ischemia-induced interleukin-6 as a potential endogenous neuroprotective cytokine against NMDA receptor-mediated excitotoxicity in the brain. J Cereb Blood Flow Metab20:956–966.
4.
Armario A
, Hernandez J, Bluethmann H, Hidalgo J.1998. IL-6 deficiency leads to increased emotionality in mice: evidence in transgenic mice carrying a null mutation for IL-6. J Neuroimmunol92:160–169.
5.
Biber K
, Lubrich B, Fiebich BL, Boddeke HW, van Calker D.2001. Interleukin-6 enhances expression of adenosine A(1) receptor mRNA and signaling in cultured rat cortical astrocytes and brain slices. Neuropsychopharmacology24:86–96.
6.
Bluthé R
, Michaud B, Poli V, Dantzer R.2000. Role of IL-6 in cytokine-induced sickness behavior. A study with IL-6 deficient mice. Physiol Behav70:367–373.
7.
Bordet T
, Castelnau-Ptakhine L, Fauchereau F, Friocourt G, Kahn A, Haase G.2001. Neuronal targeting of cardiotrophin-1 by coupling with tetanus toxin c fragment. Mol Cell Neurosci17:842–854.
8.
Brett FM
, Mizisin AP, Powell HC, Campbell IL. 1995. Evolution of neuropathologic abnormalities associated with blood-brain barrier breakdown in transgenic mice expressing interleukin-6 in astrocytes. J Neuropathol Exp Neurol54:766–775.
9.
Butterweck V
, Prinz S, Schwaninger M.2000. The role of interleukin-6 in stress-induced hyperthermia and emotional behaviour in mice. Naunyn Schmiedeberg's Arch Pharmacol361(Suppl 4):R103-R103.
10.
Campbell IL
, Abraham CR, Masliah E, Kemper P, Inglis JD, Oldstone MB, and others. 1993. Neurologic disease induced in transgenic mice by cerebral overexpression of interleukin 6. Proc Natl Acad Sci U S A90:10061–10065.
11.
Carlson NG
, Wieggel WA, Chen J, Bacchi A, Rogers SW, Gahring LC. 1999. Inflammatory cytokines IL-1 alpha, IL-1 beta, IL-6, and TNF-alpha impart neuroprotection to an excitotoxin through distinct pathways. J Immunol163:3963–3968.
12.
Chai Z
, Gatti S, Toniatti C, Poli V, Bartfai T.1996. Interleukin (IL)-6 gene expression in the central nervous system is necessary for fever response to lipopolysaccharide or IL-1β: a study on IL-6-deficient mice. J Exp Med183:311–316.
13.
Connor TJ
, Leonard BE. 1998. Depression, stress and immunological activation: the role of cytokines in depressive disorders. Life Sci62:583–606.
14.
Corbett D
, Thornhill J.2000. Temperature modulation (hypothermic and hyperthermic conditions) and its influence on histological and behavioral outcomes following cerebral ischemia. Brain Pathol10:145–152.
15.
D'Arcangelo G
, Tancredi V, Onofri F, D'Antuono M, Giovedi S, Benfenati F.2000. Interleukin-6 inhibits neurotransmitter release and the spread of excitation in the rat cerebral cortex. Eur J Neurosci12:1241–1252.
16.
De Simoni MG
, Perego C, Ravizza T, Moneta D, Conti M, Marchesi F, and others. 2000. Inflammatory cytokines and related genes are induced in the rat hippocampus by limbic status epilepticus. Eur J Neurosci12:2623–2633.
Gadient RA
, Otten U.1994. Identification of interleukin-6 (IL-6)expressing neurons in the cerebellum and hippocampus of normal adult rats. Neurosci Lett182:243–246.
19.
Gadient RA
, Otten UH. 1997. Interleukin-6 (IL-6)-a molecule with both beneficial and destructive potentials. Prog Neurobiol52:379–390.
20.
Ghosh A
, Carnahan J, Greenberg ME. 1994. Requirement for BDNF in activity-dependent survival of cortical neurons. Science263:1618–1623.
21.
Goldberg JL
, Barres BA. 2000. The relationship between neuronal survival and regeneration. Annu Rev Neurosci23:579–612.
22.
Hans VHJ
, Kossmann T, Lenzlinger PM, Probstmeier R, Imhof H-G, Trentz O, and others. 1999. Experimental axonal injury triggers interleukin-6 mRNA, protein synthesis and release into cerebrospinal fluid. J Cereb Blood Flow Metab19:184–194.
23.
Hayashi M
, Ueyama T, Nemoto K, Tamaki T, Senba E.2000. Sequential mRNA expression for immediate early genes, cytokines, and neurotrophins in spinal cord injury. J Neurotrauma17:203–218.
24.
Heinrich PC
, Behrmann I, Muller-Newen G, Schaper F, Graeve L.1998. Interleukin-6-type cytokine signalling through the gp130/ Jak/STAT pathway. Biochem J334:297–314.
25.
Herrmann O
, Tarabin V, Attigah N, Prinz S, Schneider A, Brombacher F, Schwaninger M.2001. Regulation of body temperature and neuroprotection by endogenous interleukin-6 in focal cerebral ischemia. Submitted.
26.
Horton AR
, Barlett PF, Pennica D, Davies AM. 1998. Cytokines promote the survival of mouse cranial sensory neurones at different developmental stages. Eur J Neurosci10:673–679.
27.
Jones SA
, Horiuchi S, Topley N, Yamamoto N, Fuller GM. 2001. The soluble interleukin 6 receptor: mechanisms of production and implications in disease. FASEB J15:43–58.
28.
Kasckow JW
, Regmi A, Gill PS, Parkes DG, Geracioti TD. 1997. Regulation of corticotropin-releasing factor (CRF) messenger ribonucleic acid and CRF peptide in the amygdala: studies in primary amygdalar cultures. Endocrinology138:4774–4782.
29.
Koike T
, Martin DP, Johnson EM Jr.1989. Role of Ca2+ channels in the ability of membrane depolarization to prevent neuronal death induced by trophic-factor deprivation: evidence that levels of internal Ca2+ determine nerve growth factor dependence of sympathetic ganglion cells. Proc Natl Acad Sci U S A86:6421–6425.
30.
Kunioku H
, Inoue K, Tomida M.2001. Interleukin-6 protects rat PC12 cells from serum deprivation or chemotherapeutic agents through the phosphatidylinositol 3-kinase and STAT3 pathways. Neurosci Lett309:13–16.
31.
Kurek J.2000. AM424: history of a novel drug candidate. Clin Exp Pharmacol Physiol27:553–557.
32.
März P
, Heese K, Dimitriades-Schmutz B, Rose-John S, Otten U.1999. Role of interleukin-6 and soluble IL-6 receptor in region-specific induction of astrocytic differentiation and neurotrophin expression. Glia26:191–200.
33.
Matsuda S
, Wen TC, Morita F, Otsuka H, Igase K, Yoshimura H, and others. 1996. Interleukin-6 prevents ischemia-induced learning disabilities and neuronal and synaptic loss in gerbils. Neurosci Lett204:109–112.
34.
McAllister AK
, Katz LC, Lo DC. 1999. Neurotrophins and synaptic plasticity. Annu Rev Neurosci22:295–318.
35.
Middleton G
, Hamanoue M, Enokido Y, Wyatt S, Pennica D, Jaffray E, and others. 2000. Cytokine-induced nuclear factor kappa B activation promotes the survival of developing neurons. J Cell Biol148:325–332.
36.
Müller T
, Blum-Degen D, Przuntek H, Kuhn W.1998. Interleukin-6 levels in cerebrospinal fluid inversely correlate to severity of Parkinson's disease. Acta Neurol Scand98:142–144.
37.
Murphy PG
, Borthwick LS, Johnston RS, Kuchel G, Richardson PM. 1999. Nature of the retrograde signal from injured nerves that induces interleukin-6 mRNA in neurons. J Neurosci19:3791–3780.
38.
Nakashima K
, Wiese S, Yanagisawa M, Arakawa H, Kimura N, Hisatsune T, and others. 1999. Developmental requirement of gp130 signaling in neuronal survival and astrocyte differentiation. J Neurosci19:5429–5434.
39.
Oppenheim RW
, Wiese S, Prevette D, Armanini M, Wang S, Houenou LJ, and others. 2001. Cardiotrophin-1, a muscle-derived cytokine, is required for the survival of subpopulations of developing motoneurons. J Neurosci21:1283–1291.
40.
Peltola J
, Palmio J, Korhonen L, Suhonen J, Miettinen A, Hurme M, and others. 2000. Interleukin-6 and interleukin-1 receptor antagonist in cerebrospinal fluid from patients with recent tonic-clonic seizures. Epilepsy Res41:205–211.
41.
Penkowa M
, Molinero A, Carrasco J, Hidalgo J.2001. Interleukin-6 deficiency reduces the brain inflammatory response and increases oxidative stress and neurodegeneration after kainic acid-induced seizures. Neuroscience102:805–818.
42.
Qiu Z
, Sweeney DD, Netzeband JG, Gruol DL. 1998. Chronic inter-leukin-6 alters NMDA receptor-mediated membrane responses and enhances neurotoxicity in developing CNS neurons. J Neurosci18:10445–10456.
43.
Reichenberg A
, Yirmiya R, Schuld A, Kraus T, Haack M, Morag A, and others. 2001. Cytokine-associated emotional and cognitive disturbances in humans. Arch Gen Psychiatry58:445–452.
44.
Ringheim GE
, Burgher KL, Heroux JA. 1995. Interleukin-6 mRNA expression by cortical neurons in culture: evidence for neuronal sources of interleukin-6 production in the brain. J Neuroimmunol63:113–123.
45.
Ruzek MC
, Miller AH, Opal SM, Pearce BD, Biron CA. 1997. Characterization of early cytokine responses and an interleukin (IL)-6-dependent pathway of endogenous glucocorticoid induction during murine cytomegalovirus infection. J Exp Med185:1185–1192.
46.
Sallmann S
, Jüttler E, Prinz S, Petersen N, Knopf U, Weiser T, and others. 2000. Induction of interleukin-6 by depolarization of neurons. J Neurosci20:8637–8642.
47.
Schneider A
, Martin-Villalba A, Weih F, Wirth T, Schwaninger M.1999. NF-κB is activated and promotes cell death in focal cerebral ischemia. Nat Med5:554–559.
48.
Schöbitz B
, De Kloet ER, Holsboer F.1994. Gene expression and function of interleukin 1, interleukin 6 and tumor necrosis factor in the brain. Prog Neurobiol44:397–432.
49.
Soler RM
, Egea J, Mintenig GM, Sanz-Rodriguez C, Iglesias M, Comella JX. 1998. Calmodulin is involved in membrane depolarization-mediated survival of motoneurons by phosphatidylinositol- 3 kinase- and MAPK-independent pathways. J Neurosci18:1230–1239.
50.
Straub RH
, Herrmann M, Berkmiller G, Frauenholz T, Lang B, Scholmerich J, and others. 1997. Neuronal regulation of interleukin- 6 secretion in murine spleen: adrenergic and opioidergic control. J Neurochem68:1633–1639.
51.
Strauss S
, Bauer J, Ganter U, Jonas U, Berger M, Volk B.1992. Detection of interleukin-6 and alpha 2-macroglobulin immunoreactivity in cortex and hippocampus of Alzheimer's disease patients. Lab Invest66:223–230.
52.
Sugiura S
, Lahav R, Han J, Kou SY, Banner LR, de Pablo F, and others. 2000. Leukaemia inhibitory factor is required for normal inflammatory responses to injury in the peripheral and central nervous systems in vivo and is chemotactic for macrophages in vitro. Eur J Neurosci12:457–466.
53.
Suzuki S
, Tanaka K, Nogawa S, Dembo T, Kosakai A, Fukuuchi Y.2000a. Expression of interleukin-6 is suppressed by inhibition of voltage-sensitive Na+/Ca2+ channels after cerebral ischemia. Neuroreport11:2565–2569.
54.
Suzuki S
, Tanaka K, Nogawa S, Ito D, Dembo T, Kosakai A, and others. 2000b. Immunohistochemical detection of leukemia inhibitory factor after focal cerebral ischemia in rats. J Cereb Blood Flow Metab20:661–668.
55.
Suzuki S
, Tanaka K, Nogawa S, Nagata E, Ito D, Dembo T, and others. 1999. Temporal profile and cellular localization of interleukin-6 protein after focal cerebral ischemia in rats. J Cereb Blood Flow Metab19:1256–1262.
56.
Tancredi V
, D'Antuono M, Cafe C, Giovedi S, Bue MC, D'Arcangelo G, and others. 2000. The inhibitory effects of interleukin-6 on synaptic plasticity in the rat hippocampus are associated with an inhibition of mitogen-activated protein kinase ERK. J Neurochem75:634–643.
57.
Tarkowski E
, Rosengren L, Blomstrand C, Wikkelsö C, Jensen C, Ekholm S, and others. 1995. Early intrathecal production of interleukin- 6 predicts the size of brain lesion in stroke. Stroke26:1393–1398.
58.
Vitkovic L
, Bockaert J, Jacque C.2000. “Inflammatory” cytokines: neuromodulators in normal brain?J Neurochem74:457–471.
59.
Watanabe D
, Yoshimura R, Khalil M, Yoshida K, Kishimoto T, Taga T, and others. 1996. Characteristic localization of gp130 (the signal-transducing receptor component used in common for IL-6/IL- 11/CNTF/LIF/OSM) in the rat brain. Eur J Neurosci8:1630–1640.
60.
Zhong J
, Dietzel ID, Wahle P, Kopf M, Heumann R.1999. Sensory impairment and delayed regeneration of sensory axons in inter-leukin-6-deficient mice. J Neurosci19:4305–4313.
